NIH-funded research Fellowship grant

Understanding how the extracellular matrix affects heart defects in Down Syndrome.

Official title: Investigating the Role of Extracellular Matrix in Down Syndrome Associated Cardiac Phenotypes.

Funded at Massachusetts Institute of Technology · NIH-11070768 · Data updated 2026-11-12

This study is looking at how changes in the heart's support structure might lead to heart problems in babies with Down Syndrome, using special cells to create 3D heart models to better understand what goes wrong during heart development.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionMassachusetts Institute of Technology
NIH-funded
Lab location1 site (Cambridge, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2028
Funding year2025
Award (this year)$77,284
NIH project number1F32HL178155-01
Project IDNIH-11070768 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include infants diagnosed with Down Syndrome who are at risk for congenital heart defects.

Less likely to help

Patients without Down Syndrome or those who do not have congenital heart defects may not benefit from this research.

What this research studies

This research investigates the role of the extracellular matrix (ECM) in causing congenital heart defects (CHD) in infants with Down Syndrome. By using human induced pluripotent stem cells (hiPSCs) derived from individuals with Down Syndrome, the study aims to explore how changes in the ECM during heart development can lead to abnormal heart structures. The researchers will create 3D cardiac models to analyze the molecular and cellular interactions that contribute to these defects, focusing on how ECM alterations affect heart cell behavior and development.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential treatments for congenital heart defects in infants with Down Syndrome.

How similar studies have gone: Other research has shown promising results in understanding cardiac defects through similar approaches, but this specific investigation into the ECM in Down Syndrome is relatively novel.

Where this research is happening

  • Massachusetts Institute of Technology
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Borden, Leah K — Massachusetts Institute of Technology
  • Study coordinator: Borden, Leah K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.